Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Hank Payments Achieves Record Growth in its Profitable Auto Channel (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Infinity Pharmaceuticals Inc INFIQ

Healthcare Biotechnology
Infinity Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that is focused on developing medicines for people with cancer. The Company is focused on advancing eganelisib, also known as IPI-549, an orally administered, clinical-stage, immuno-oncology product candidate that reprograms macrophages through selective inhibition of the enzyme phosphoinositide-3-kinase-gamma (PI3K... see more

Recent & Breaking News (GREY:INFIQ)

Mid-Afternoon Market Update: OPKO Health Rises On Q3 Earnings; Lumentum Shares Plummet

Benzinga.com  November 12, 2018

Mid-Day Market Update: Dow Down Over 400 Points; Apptio Shares Spike Higher

Benzinga.com  November 12, 2018

Mid-Morning Market Update: Markets Open Lower; Veritas Capital To Buy Athenahealth For $5.7B

Benzinga.com  November 12, 2018

Infinity Reports Clinical and Translational Data from Expansion Cohorts of MARIO‑1 Phase 1b Study of IPI-549 in Combination with Opdivo® (nivolumab) at SITC's 33rd Annual Meeting

PR Newswire November 10, 2018

Detailed Research: Economic Perspectives on MetLife, Callon Petroleum, Five9, Ballard Power, Infinity Pharmaceuticals, and Commercial Vehicle Group — What Drives Growth in Today's Competitive Landscape

GlobeNewswire November 9, 2018

Infinity Pharmaceuticals Provides Company Update and Third Quarter 2018 Financial Results

PR Newswire November 5, 2018

Bristol-Myers Squibb and Infinity Pharmaceuticals Announce a New Clinical Collaboration to Evaluate Opdivo (Nivolumab) in Combination with IPI-549 in Urothelial Cancer

Business Wire November 5, 2018

Infinity Announces IPI-549 Late-Breaking Presentation at SITC 33rd Annual Meeting

PR Newswire November 1, 2018

Infinity Announces the Date of Its Third Quarter 2018 Financial Results Conference Call and Webcast

PR Newswire October 29, 2018

Report: Exploring Fundamental Drivers Behind Infinity Pharmaceuticals, AxoGen, MUELLER WATER PRODUCTS, MYR Group, RealNetworks, and Odonate Therapeutics — New Horizons, Emerging Trends, and Upcoming Developments

GlobeNewswire October 17, 2018

Infinity To Present At BIO Investor Forum

PR Newswire October 11, 2018

45 Biggest Movers From Yesterday

Benzinga.com  October 3, 2018

38 Stocks Moving In Tuesday's Mid-Day Session

Benzinga.com  October 2, 2018

Infinity Pharmaceuticals Earns $22 Million Payment From Verastem Oncology For FDA Approval Of COPIKTRA™ (duvelisib) And Updates 2018 Financial Guidance

PR Newswire October 1, 2018

Infinity To Present At Cantor Fitzgerald Global Healthcare Conference

PR Newswire September 26, 2018

Infinity To Present At Three Upcoming Investor Conferences In September

PR Newswire August 28, 2018

Research Report Identifies America's Car-Mart, SAExploration, Ascena Retail Group, Infinity Pharmaceuticals, Hologic, and California Resources with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement

GlobeNewswire August 22, 2018

Infinity Pharmaceuticals Provides Company Update and Second Quarter 2018 Financial Results

PR Newswire August 7, 2018

Infinity Pharmaceuticals Appoints Samuel Agresta, M.D., M.P.H. as Chief Medical Officer

PR Newswire August 7, 2018

Infinity Announces The Date Of Its Second Quarter 2018 Financial Results Conference Call And Webcast

PR Newswire July 31, 2018